Related Experiment Video
Updated: Feb 12, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W Robey1, Kristen M Pluchino1, Matthew D Hall2
1Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Abstract:
Most patients who die of cancer have disseminated disease that has become resistant to multiple therapeutic modalities. Ample evidence suggests that the expression of ATP-binding cassette (ABC) transporters, especially the multidrug resistance protein 1 (MDR1, also known as P-glycoprotein or P-gp), which is encoded by ABC subfamily B member 1 (ABCB1), can confer resistance to cytotoxic and targeted chemotherapy. However, the development of MDR1 as a therapeutic target has been unsuccessful. At the time of its discovery, appropriate tools for the characterization and clinical development of MDR1 as a therapeutic target were lacking. Thirty years after the initial cloning and characterization of MDR1 and the implication of two additional ABC transporters, the multidrug resistance-associated protein 1 (MRP1; encoded by ABCC1)), and ABCG2, in multidrug resistance, interest in investigating these transporters as therapeutic targets has waned. However, with the emergence of new data and advanced techniques, we propose to re-evaluate whether these transporters play a clinical role in multidrug resistance. With this Opinion article, we present recent evidence indicating that it is time to revisit the investigation into the role of ABC transporters in efficient drug delivery in various cancer types and at the blood-brain barrier.
Insights
Investigating ATP-binding cassette (ABC) transporters, like multidrug resistance protein 1 (MDR1), is crucial for overcoming cancer drug resistance. New evidence suggests revisiting these transporters for improved cancer therapy and drug delivery, especially at the blood-brain barrier.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) in cancer, often due to ATP-binding cassette (ABC) transporters, limits therapeutic efficacy.
- Multidrug resistance protein 1 (MDR1/P-glycoprotein/P-gp), encoded by ABCB1, is a key transporter implicated in chemotherapy resistance.
- Past efforts to target MDR1 therapeutically were hindered by a lack of adequate tools and understanding.
Purpose of the Study:
- To re-evaluate the clinical significance of ABC transporters in mediating multidrug resistance in various cancer types.
- To explore the potential of targeting ABC transporters for enhancing drug delivery, particularly across the blood-brain barrier.
- To present recent evidence supporting a renewed investigation into ABC transporters as therapeutic targets.
Main Methods:
- Review and synthesis of recent scientific literature and emerging data on ABC transporters in cancer.
- Analysis of the role of MDR1, ABCC1 (MRP1), and ABCG2 in drug resistance mechanisms.
- Examination of the implications of ABC transporter activity at the blood-brain barrier.
Main Results:
- Evidence suggests that ABC transporters, including MDR1, MRP1, and ABCG2, continue to play a significant role in cancer multidrug resistance.
- Recent advancements in technology and data provide new opportunities for characterizing and targeting these transporters.
- The blood-brain barrier presents a critical area where ABC transporters influence drug penetration and efficacy.
Conclusions:
- It is timely to revisit the investigation of ABC transporters as therapeutic targets in oncology.
- Targeting ABC transporters could offer novel strategies for improving chemotherapy effectiveness and drug delivery in cancer patients.
- Further research into ABC transporter function is warranted to overcome drug resistance and enhance treatment outcomes.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Treatment Resistant Cancers
Hepatic Drug Clearance: Role of Transporters
Facilitated Transport